{"id":"W4232838246","doi":"10.1200/jco.2015.33.15_suppl.tps5077","title":"Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: the ANZUP ENZAMET Trial (ANZUP 1304).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Androgen deprivation therapy; Internal medicine; Oncology; Hazard ratio; Docetaxel; Hormone therapy; Adverse effect; Cancer; Androgen receptor; Breast cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002055057,0.001748411,0.00258428,0.0003262497,0.0003298601,0.0009522276,0.0008827342,0.001591241,0.01060743],"category_scores_gemma":[0.001959512,0.0005163663,0.002573136,0.0003014955,0.0006513585,0.0009186512,0.0005496285,0.00244775,0.00108153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001184584,"about_ca_system_score_gemma":0.001480412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002226272,"about_ca_topic_score_gemma":0.00753776,"domain_scores_codex":[0.9991192,0.000609398,0.00003080314,0.0001025281,0.00005481125,0.00008318039],"domain_scores_gemma":[0.9994466,0.0001487774,0.0001585492,0.00004436383,0.00004858358,0.000153061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9825923,0.001552215,0.0006142932,0.0009915524,0.001467271,0.00003865264,0.00003238639,0.0004467165,0.001041825,0.000138161,0.001516347,0.009568401],"study_design_scores_gemma":[0.9740217,0.02097421,0.002083076,0.00007238914,0.0007971227,0.00003918482,0.00001607981,0.0002961056,0.0001160458,0.0002714788,0.001299559,0.00001314877],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9496846,0.0168415,0.001075464,0.002344468,0.001236796,0.01395783,0.006707147,0.0002501059,0.007902049],"genre_scores_gemma":[0.9565127,0.005318928,0.00317931,0.003673556,0.0005256487,0.01536442,0.005910745,0.0000465795,0.009468107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01060743,"threshold_uncertainty_score":0.03548539,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3234078936328013,"score_gpt":0.5553874240841372,"score_spread":0.231979530451336,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}